1 | correction | 3,227 |
2 | ingestion | 2,544 |
3 | co-administration | 658 |
4 | coadministration | 625 |
5 | transfection | 507 |
6 | corrections | 259 |
7 | reintroduction | 97 |
8 | microinjection | 69 |
9 | haploinsufficiency | 58 |
10 | radiolabeling | 36 |
11 | hyperhydration | 33 |
12 | pre-administration | 32 |
13 | co-ingestion | 25 |
14 | coinfusion | 24 |
15 | pre-treatments | 22 |
16 | pinealectomy | 21 |
17 | phytotoxicity | 19 |
18 | bioaugmentation | 18 |
19 | photoactivation | 18 |
20 | reclosure | 18 |
21 | coprescription | 16 |
22 | reapplication | 13 |
23 | restimulation | 12 |
24 | cotransfection | 11 |
25 | adjuvantation | 9 |
26 | co-amplification | 9 |
27 | co-transfection | 9 |
28 | transfections | 9 |
29 | co-culturing | 8 |
30 | coinjection | 8 |
31 | self-comparison | 8 |
32 | disregulation | 7 |
33 | nanoencapsulation | 7 |
34 | alcoholization | 6 |
35 | caging | 6 |
36 | co-cultivation | 6 |
37 | diafiltration | 5 |
38 | re-stimulation | 5 |
39 | araucaria | 4 |
40 | co-fermentation | 4 |
41 | elixirs | 4 |
42 | estrogenization | 4 |
43 | photoassociation | 4 |
44 | anteromedialization | 3 |
45 | coimplantation | 3 |
46 | muts2 | 3 |
47 | casefinding | 2 |
48 | coproduction | 2 |
49 | mark-recapture | 2 |
50 | mdl-approach | 2 |
51 | molality | 2 |
52 | overdrilling | 2 |
53 | post-adjustment | 2 |
54 | preabsorption | 2 |
55 | split-dosing | 2 |
56 | alpha-adjustments | 1 |
57 | ato/chemotherapy | 1 |
58 | bonferrroni | 1 |
59 | cc-hmg | 1 |
60 | co-polyacetal | 1 |
61 | compression∕elongation | 1 |
62 | cycloamination | 1 |
63 | deferiprone–deferoxamine | 1 |
64 | doxorubicin/paclitaxel | 1 |
65 | drink/d | 1 |
66 | fec-docetaxel | 1 |
67 | fixed-cycles | 1 |
68 | get-up-and-go-test | 1 |
69 | lndoses | 1 |
70 | maternal-report | 1 |
71 | methotrexate/5-fluorouracil | 1 |
72 | mmc/adriamycin | 1 |
73 | pharamacotherapy | 1 |
74 | post-return | 1 |
75 | quadritherapy | 1 |
76 | radio-hormono-therapy | 1 |
77 | sequentialtherapy | 1 |
78 | sucrose-gradient | 1 |
1 | adjuvantation | 9 |
2 | alcoholization | 6 |
3 | alpha-adjustments | 1 |
4 | anteromedialization | 3 |
5 | araucaria | 4 |
6 | ato/chemotherapy | 1 |
7 | bioaugmentation | 18 |
8 | bonferrroni | 1 |
9 | caging | 6 |
10 | casefinding | 2 |
11 | cc-hmg | 1 |
12 | co-administration | 658 |
13 | co-amplification | 9 |
14 | co-cultivation | 6 |
15 | co-culturing | 8 |
16 | co-fermentation | 4 |
17 | co-ingestion | 25 |
18 | co-polyacetal | 1 |
19 | co-transfection | 9 |
20 | coadministration | 625 |
21 | coimplantation | 3 |
22 | coinfusion | 24 |
23 | coinjection | 8 |
24 | compression∕elongation | 1 |
25 | coprescription | 16 |
26 | coproduction | 2 |
27 | correction | 3,227 |
28 | corrections | 259 |
29 | cotransfection | 11 |
30 | cycloamination | 1 |
31 | deferiprone–deferoxamine | 1 |
32 | diafiltration | 5 |
33 | disregulation | 7 |
34 | doxorubicin/paclitaxel | 1 |
35 | drink/d | 1 |
36 | elixirs | 4 |
37 | estrogenization | 4 |
38 | fec-docetaxel | 1 |
39 | fixed-cycles | 1 |
40 | get-up-and-go-test | 1 |
41 | haploinsufficiency | 58 |
42 | hyperhydration | 33 |
43 | ingestion | 2,544 |
44 | lndoses | 1 |
45 | mark-recapture | 2 |
46 | maternal-report | 1 |
47 | mdl-approach | 2 |
48 | methotrexate/5-fluorouracil | 1 |
49 | microinjection | 69 |
50 | mmc/adriamycin | 1 |
51 | molality | 2 |
52 | muts2 | 3 |
53 | nanoencapsulation | 7 |
54 | overdrilling | 2 |
55 | pharamacotherapy | 1 |
56 | photoactivation | 18 |
57 | photoassociation | 4 |
58 | phytotoxicity | 19 |
59 | pinealectomy | 21 |
60 | post-adjustment | 2 |
61 | post-return | 1 |
62 | pre-administration | 32 |
63 | pre-treatments | 22 |
64 | preabsorption | 2 |
65 | quadritherapy | 1 |
66 | radio-hormono-therapy | 1 |
67 | radiolabeling | 36 |
68 | re-stimulation | 5 |
69 | reapplication | 13 |
70 | reclosure | 18 |
71 | reintroduction | 97 |
72 | restimulation | 12 |
73 | self-comparison | 8 |
74 | sequentialtherapy | 1 |
75 | split-dosing | 2 |
76 | sucrose-gradient | 1 |
77 | transfection | 507 |
78 | transfections | 9 |
1 | muts2 | 3 |
2 | araucaria | 4 |
3 | drink/d | 1 |
4 | deferiprone–deferoxamine | 1 |
5 | reclosure | 18 |
6 | mark-recapture | 2 |
7 | cc-hmg | 1 |
8 | casefinding | 2 |
9 | caging | 6 |
10 | radiolabeling | 36 |
11 | overdrilling | 2 |
12 | co-culturing | 8 |
13 | split-dosing | 2 |
14 | mdl-approach | 2 |
15 | bonferrroni | 1 |
16 | co-polyacetal | 1 |
17 | fec-docetaxel | 1 |
18 | doxorubicin/paclitaxel | 1 |
19 | methotrexate/5-fluorouracil | 1 |
20 | mmc/adriamycin | 1 |
21 | coinfusion | 24 |
22 | co-amplification | 9 |
23 | reapplication | 13 |
24 | compression∕elongation | 1 |
25 | photoassociation | 4 |
26 | disregulation | 7 |
27 | re-stimulation | 5 |
28 | restimulation | 12 |
29 | nanoencapsulation | 7 |
30 | cycloamination | 1 |
31 | hyperhydration | 33 |
32 | diafiltration | 5 |
33 | pre-administration | 32 |
34 | co-administration | 658 |
35 | coadministration | 625 |
36 | coimplantation | 3 |
37 | adjuvantation | 9 |
38 | bioaugmentation | 18 |
39 | co-fermentation | 4 |
40 | photoactivation | 18 |
41 | co-cultivation | 6 |
42 | anteromedialization | 3 |
43 | alcoholization | 6 |
44 | estrogenization | 4 |
45 | transfection | 507 |
46 | co-transfection | 9 |
47 | cotransfection | 11 |
48 | coinjection | 8 |
49 | microinjection | 69 |
50 | correction | 3,227 |
51 | coproduction | 2 |
52 | reintroduction | 97 |
53 | coprescription | 16 |
54 | preabsorption | 2 |
55 | ingestion | 2,544 |
56 | co-ingestion | 25 |
57 | self-comparison | 8 |
58 | post-return | 1 |
59 | fixed-cycles | 1 |
60 | lndoses | 1 |
61 | transfections | 9 |
62 | corrections | 259 |
63 | elixirs | 4 |
64 | pre-treatments | 22 |
65 | alpha-adjustments | 1 |
66 | sucrose-gradient | 1 |
67 | post-adjustment | 2 |
68 | maternal-report | 1 |
69 | get-up-and-go-test | 1 |
70 | haploinsufficiency | 58 |
71 | pinealectomy | 21 |
72 | radio-hormono-therapy | 1 |
73 | quadritherapy | 1 |
74 | sequentialtherapy | 1 |
75 | pharamacotherapy | 1 |
76 | ato/chemotherapy | 1 |
77 | phytotoxicity | 19 |
78 | molality | 2 |